Convenience of one prescription and one dosing schedule with a clarithromycin–free regimen1

Talicia ~ Omeprazole magnesium, amoxicillin, and rifabutin delayed-release capsules

All-in-one proprietary formulation for simple dosing2

Orange capsule of TALICIA (omeprazole magnesium, amoxicillin, and rifabutin)

Each Talicia capsule contains2:
10.3 mg omeprazole magnesium,
250 mg amoxicillin, and 12.5 mg rifabutin

Capsule shown not actual size.

24-hour antibiotic exposure icon

Maintains antibiotic exposure
at the site of infection for >90% of a
24-hour period2

Only Talicia contains 2 antimicrobials with zero-to-minimal H. pylori resistance, which may lead to greater eradication success3

Talicia

rifabutin
0.0%*
amoxicillin
6.4%*

Other H. pylori antibiotics

clarithromycin
17.4%*
metronidazole
43.6%*
*Resistance rates as determined by in vitro testing of 345 H. pylori isolates collected at baseline from patients enrolled in the Talicia pivotal trial.

Available generic formulations are not therapeutically equivalent to the low-dose rifabutin component of Talicia2

Simple Dosing

Dosing instructions for Talicia

4 orange capsules
4
orange
capsules
3 times daily
3
times
daily
with food
14 days of antibiotic treatment
14
days

Pharmacokinetic Profile

PBPK modeling demonstrates that Talicia maintains intragastric rifabutin concentrations ≥H. pylori MIC90 for >90% of a 24-hour period2

of the day
0 %
of the day
0 %
of the day
0 %

MIC90=minimum inhibitory concentration; PBPK=physiologically based pharmacokinetic.

References: 1. TALICIA Prescribing Information. RedHill Biopharma Inc.; 2024. 2. Howden CW, Shah S, Pendse SN, Offman E, Almenoff JS, Sheldon KL. Physiologically-based pharmacokinetic modelling to predict intragastric rifabutin concentrations in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 2023;58(2):159-167. 3. Graham DY, Canaan Y, Maher J, Wiener G, Hulten KG, Kalfus IN. Rifabutin-based triple therapy (RHB-105) for Helicobacter pylori eradication: a double-blind, randomized, controlled trial. Ann Intern Med. 2020;172(12):795-802.

Are you a US healthcare professional?

This site is intended for US healthcare professionals only.
If you are a healthcare professional, click “YES” to proceed.